Quantum Biopharma (QNTM) Capital Expenditures (2019 - 2026)
Quantum Biopharma (QNTM) posted Capital Expenditures of -$3.0 million for Q1 2026, down 234.76% sequentially from -$884881.0 in Q3 2025, and down 5.79% YoY from -$3.1 million in Q1 2025.
Quantum Biopharma (QNTM) Capital Expenditures (2019 - 2026) Analysis & Trends
Quantum Biopharma has reported Capital Expenditures for 7 years, with the latest figure at -$3.0 million in Q1 2026.
- Quarterly Capital Expenditures fell 5.79% year-over-year to -$3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$8.1 million (down 191.38% YoY) and the FY2022 annual result came in at $113958.0, changed N/A from the prior year.
- Capital Expenditures retreated to -$3.0 million in Q1 2026 per QNTM's latest filing, from -$884881.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $3.5 million in Q4 2024 and troughed at -$3.5 million in Q3 2024.
- A 5-year average of -$570015.1 and a median of -$59528.5 in 2022 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2024 and 2025: Capital Expenditures surged 368.16% in 2024, then tumbled 651924.32% in 2025.
- Over 5 years, Capital Expenditures stood at $230839.0 in 2022, then soared by 222.52% to $744500.0 in 2023, then soared by 368.16% to $3.5 million in 2024, then tumbled by 125.39% to -$884881.0 in 2025, then tumbled by 234.76% to -$3.0 million in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered -$3.0 million, -$884881.0, and -$1.4 million for Q1 2026, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 34.68 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -73.57 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.26 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 251.02 Mn |
| 10 | Quantum Biopharma | 15.44 Mn | 11.80 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.96 Mn |
| Mar 31, 2026 | -2.96 Mn |
| Sep 30, 2025 | -884,881.00 |
| Sep 30, 2025 | -884,881.00 |
| Jun 30, 2025 | -1.45 Mn |
| Jun 30, 2025 | -1.45 Mn |
| Mar 31, 2025 | -2.80 Mn |
| Mar 31, 2025 | -2.80 Mn |
| Dec 31, 2024 | 3.49 Mn |
| Dec 31, 2024 | 3.49 Mn |
| Sep 30, 2024 | -3.46 Mn |
| Sep 30, 2024 | -3.46 Mn |
| Jun 30, 2024 | 222.00 |
| Jun 30, 2024 | 222.00 |
| Mar 31, 2024 | -22,140.00 |
| Mar 31, 2024 | -22,140.00 |
| Dec 31, 2023 | 744,500.00 |
| Dec 31, 2023 | 744,500.00 |
| Sep 30, 2023 | -744,500.00 |
| Sep 30, 2023 | -744,500.00 |